Skip to main content
Article
Role of Exonic Variation in Chemokine Receptor Genes on AIDS: CCRL2 F167Y Association with Pneumocystis Pneumonia
PloS Genetics
  • Ping An, National Cancer Institute at Frederick
  • Rongling Li, National Human Genome Research Institute
  • Ji Ming Wang, National Cancer Institute at Frederick
  • Teizo Yoshimura, National Cancer Institute at Frederick
  • Munehisa Takahashi, National Cancer Institute at Frederick
  • Ram Samudralal, University of Washington - Seattle
  • Stephen J. O'Brien, National Cancer Institute at Frederick
  • John Phair, Northwestern University Medical School
  • James J. Goedert, National Cancer Institute at Bethesda
  • Gregory D. Kirk, Johns Hopkins University
  • Jennifer L. Troyer, National Cancer Institute at Frederick
  • Efe Sezgin, National Cancer Institute at Frederick
  • Susan Buchbinder, San Francisco Department of Public Health
  • Sharyne Donfield, Rho, Inc.
  • George W. Nelson, National Cancer Institute at Frederick
  • Cheryl Winkler, National Cancer Institute at Frederick
Document Type
Article
Publication Date
10-27-2011
Abstract

Chromosome 3p21–22 harbors two clusters of chemokine receptor genes, several of which serve as major or minor coreceptors of HIV-1. Although the genetic association of CCR5 andCCR2 variants with HIV-1 pathogenesis is well known, the role of variation in other nearby chemokine receptor genes remain unresolved. We genotyped exonic single nucleotide polymorphisms (SNPs) in chemokine receptor genes: CCR3, CCRL2, and CXCR6 (at 3p21) and CCR8 and CX3CR1 (at 3p22), the majority of which were non-synonymous. The individual SNPs were tested for their effects on disease progression and outcomes in five treatment-naïve HIV-1/AIDS natural history cohorts. In addition to the known CCR5 and CCR2associations, significant associations were identified for CCR3, CCR8, and CCRL2 on progression to AIDS. A multivariate survival analysis pointed to a previously undetected association of a non-conservative amino acid change F167Y in CCRL2 with AIDS progression: 167F is associated with accelerated progression to AIDS (RH = 1.90, P = 0.002, corrected). Further analysis indicated that CCRL2-167F was specifically associated with more rapid development of pneumocystis pneumonia (PCP) (RH = 2.84, 95% CI 1.28–6.31) among four major AIDS–defining conditions. Considering the newly defined role of CCRL2 in lung dendritic cell trafficking, this atypical chemokine receptor may affect PCP through immune regulation and inducing inflammation.

Comments

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Additional Comments
National Cancer Institute contract #: HHSN261200800001E
ORCID ID
0000-0001-7353-8301
ResearcherID
N-1726-2015
Citation Information
Ping An, Rongling Li, Ji Ming Wang, Teizo Yoshimura, et al.. "Role of Exonic Variation in Chemokine Receptor Genes on AIDS: CCRL2 F167Y Association with Pneumocystis Pneumonia" PloS Genetics Vol. 7 Iss. 10 e1002328 (2011) p. 1 - 10 ISSN: 1553-7390
Available at: http://works.bepress.com/stephen-obrien/554/